risk management
FDA Urges AI Device Manufacturers for Transparency in Testing Data
NeelRatan
The FDA is enhancing oversight of AI medical devices, advocating for manufacturers to disclose more testing and performance details. New guidance emphasizes early engagement with sponsors and addresses potential risks associated with AI technologies in clinical settings.
Harnessing Team Insights to Manage Gen AI Risks Effectively
NeelRatan
A recent article emphasizes the importance of leveraging collective judgment to address the risks associated with generative AI. By collaborating and drawing on diverse perspectives within teams, organizations can better navigate challenges and make informed decisions about integrating this technology into their operations.
